Peptide-mediated cellular uptake of cryptophane

Area of Science:

• Biomedical Engineering
• Molecular Imaging
• Biochemistry

Background:

• Cryptophane-A exhibits high affinity for xenon, making it promising for xenon (129)Xe nuclear magnetic resonance (NMR) spectroscopy biosensors.
• Developing effective methods for delivering these cryptophane molecules into cells is crucial for their application in biosensing.

Purpose of the Study:

• To report the cellular delivery of three peptide-functionalized cryptophane biosensors.
• To evaluate the specificity and toxicity of these cryptophane-based biosensors in human cancer and normal cell lines.

Main Methods:

• Utilized two cationic cell-penetrating peptides for cryptophane delivery into various human cell lines.
• Employed an RGD peptide targeting the alpha(v)beta(3) integrin receptor to enhance specificity.
• Visualized cellular delivery using confocal laser scanning microscopy with Cy3-labeled peptides.
• Assessed cytotoxicity using MTT assays at micromolar concentrations.

Main Results:

• Successfully delivered peptide-functionalized cryptophanes into multiple human cancer and normal cell lines.
• Demonstrated that RGD peptide functionalization increased the specificity of cryptophane cellular uptake.
• Confirmed the ability to monitor cryptophane delivery via confocal microscopy.
• Found the peptido-cryptophanes to be relatively non-toxic at concentrations needed for (129)Xe NMR biosensing.

Conclusions:

• Peptide-functionalized cryptophanes can be effectively delivered into human cells.
• RGD peptide targeting enhances the specificity of cryptophane delivery for potential biosensing applications.
• These cryptophane biosensors exhibit low toxicity, supporting their use in (129)Xe NMR spectroscopy.